The WHO endorses the R21/Matrix-M malaria vaccine, a collaboration between the Serum Institute of India and the University of Oxford. Licensed for use in Ghana, Nigeria, and Burkina Faso, this vaccine shows promising efficacy in reducing malaria cases,